TrademarkDir
KEY PHARMA
LIVE

Serial Number

90356780

Owner

Keysource Acquisition, LLC

Attorney

Carrie A. Johnson

First Use Date

Sep 26, 2023

Filing Date

Dec 3, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

KEY PHARMA Trademark

Serial Number: 90356780 • Registration: 7249780

KEY PHARMA is a trademark filed by Keysource Acquisition, LLC on December 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Keysource Acquisition, LLC (5 trademarks)

7820 Palace Drive
Cincinnati, OH 45249

Entity Type: 16

Trademark Details

Filing Date

December 3, 2020

Registration Date

December 19, 2023

First Use Anywhere

September 26, 2023

First Use in Commerce

September 26, 2023

Published for Opposition

February 8, 2022

Goods & Services

Pharmaceuticals for pain management; pharmaceuticals for the treatment of allergies; pharmaceuticals for the treatment and prevention of digestive, cardiovascular, immune system, urology, central nervous system, respiratory, bone, eye, ear, nose, throat, dermatological, ophthalmological, endocrine, musculo-skeletal, obstetric and gynecological, urinary and gastrointestinal diseases, infections, and conditions; nutritional and dietary supplements

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 19, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 19, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 17, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 16, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 4, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 4, 2023 AITU
USE AMENDMENT FILED
Sep 26, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 26, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 19, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jan 17, 2023 EX2G
SOU EXTENSION 2 FILED
Jan 17, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 9, 2022 EXRA
SOU EXTENSION 1 GRANTED
Sep 7, 2022 EX1G
SOU EXTENSION 1 FILED
Sep 7, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 7, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 5, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 19, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 5, 2022 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2021 CRFA
ASSIGNED TO LIE
Dec 14, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Dec 10, 2021 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2021 TROA
PETITION TO REVIVE-GRANTED
Dec 10, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Dec 10, 2021 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Dec 9, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 9, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 28, 2021 GNRN
NON-FINAL ACTION E-MAILED
May 28, 2021 GNRT
NON-FINAL ACTION WRITTEN
May 28, 2021 CNRT
ASSIGNED TO EXAMINER
May 20, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2021 NWOS
NEW APPLICATION ENTERED
Dec 7, 2020 NWAP

Related Trademarks

More from this Owner

KEYSOURCE PLUS

KEYSOURCE PLUS

KEYSOURCE PLUS

KEYSOURCE PLUS

KEYSOURCE +

KEYSOURCE +

KEYSOURCE +

KEYSOURCE +

KEY PHARMA

KEY PHARMA

KEY PHARMA

KEY PHARMA